Triazine kinase inhibitors
CA 2386218 A1 · Owner: Toledo-Sherman, Leticia M. · Inventors: Elbaum, Daniel; Dipietro, Lucian V.; Toledo-Sherman, Leticia M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to inhibitors of formula (I) of enzymes that bind to ATP or GTP and/or catalyze phosphoryl transfer compositions comprising the , inhibitors and methods of using the inhibitors and inhibitor compositions. The inhibitors and compositions comprising them are useful for treating disease or disease symptoms. The invention also provides for methods of making phosphoryl transferase inhibitor compounds methods of inhibiting phosphoryl , transferase activity and methods for treating disease or disease symptoms. In formula (I), each R1 and R2 is independently R3; R8; NHR3; NHR5; NHR6; NR5R5; NR5R6; SR5; SR6; SR3; OR5; OR6; OR3; C(O)R3; heterocyclyl optionally substituted …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 6, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 6, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 6, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.